SecSonar.com

Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Foghorn Therapeutics Inc. (FHTX) is a Biotechnology company based in US with a market capitalization of $253.6M. Revenue grew 36.8% year-over-year and free cash flow was negative at -$86.1M. This page tracks FHTX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 112 employees · IPO Oct 23, 2020

Valuation

Valuation & price

$3.79 · as of May 17, 2026 · -43.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.47$5.00$3.53Jul 25Dec 25Jul 26Jul 7, 25$4.78Jul 9, 25$5.51Jul 11, 25$5.40Jul 15, 25$5.80Jul 17, 25$6.10Jul 21, 25$6.10Jul 23, 25$6.47Jul 25, 25$6.19Jul 29, 25$5.91Jul 31, 25$5.25Aug 4, 25$5.14Aug 6, 25$4.90Aug 11, 25$4.71Aug 13, 25$5.17Aug 15, 25$4.98Aug 19, 25$4.83Aug 21, 25$5.04Aug 25, 25$5.25Aug 27, 25$5.41Aug 29, 25$5.06Sep 3, 25$5.27Sep 5, 25$5.77Sep 9, 25$5.43Sep 11, 25$5.28Sep 16, 25$4.90Sep 18, 25$5.14Sep 22, 25$4.98Sep 24, 25$4.91Sep 26, 25$4.86Sep 30, 25$4.89Oct 2, 25$4.54Oct 6, 25$4.53Oct 8, 25$4.50Oct 10, 25$4.06Oct 14, 25$4.35Oct 16, 25$4.31Oct 21, 25$4.07Oct 23, 25$3.90Oct 27, 25$4.12Oct 29, 25$4.23Oct 31, 25$4.41Nov 4, 25$3.53Nov 6, 25$4.00Nov 10, 25$4.42Nov 12, 25$4.53Nov 14, 25$4.69Nov 18, 25$5.02Nov 20, 25$4.59Nov 25, 25$4.72Nov 28, 25$4.75Dec 2, 25$4.29Dec 4, 25$4.58Dec 8, 25$4.45Dec 10, 25$4.45Dec 12, 25$4.44Dec 16, 25$4.48Dec 18, 25$5.00Dec 22, 25$5.78Dec 24, 25$5.40Dec 29, 25$5.19Jan 2, 26$5.19Jan 6, 26$4.93Jan 8, 26$5.23Jan 12, 26$6.38Jan 14, 26$6.31Jan 16, 26$6.02Jan 21, 26$6.08Jan 23, 26$5.88Jan 27, 26$5.90Jan 29, 26$5.77Feb 2, 26$5.85Feb 4, 26$5.63Feb 9, 26$5.45Feb 11, 26$5.42Feb 13, 26$5.55Feb 18, 26$5.66Feb 20, 26$5.73Feb 24, 26$5.67Feb 26, 26$5.76Mar 2, 26$5.76Mar 4, 26$5.67Mar 6, 26$5.78Mar 10, 26$5.49Mar 12, 26$4.92Mar 17, 26$5.06Mar 19, 26$4.89Mar 23, 26$5.09Mar 25, 26$4.93Mar 27, 26$4.50Mar 31, 26$4.78Apr 2, 26$4.93Apr 7, 26$4.97Apr 9, 26$4.79Apr 13, 26$4.69Apr 15, 26$4.87Apr 17, 26$5.29Apr 22, 26$5.39Apr 24, 26$5.31Apr 28, 26$5.17Apr 30, 26$4.75May 4, 26$4.68May 6, 26$4.68May 8, 26$4.44May 12, 26$4.24May 14, 26$4.04May 18, 26$3.82May 20, 26$4.00May 22, 26$4.22May 28, 26$4.27Jun 1, 26$3.98Jun 3, 26$3.64Jun 5, 26$3.73Jun 9, 26$3.87Jun 11, 26$4.06Jun 15, 26$4.11Jun 17, 26$4.05Jun 22, 26$4.18Jun 24, 26$4.08Jun 26, 26$4.22Jul 2, 26$5.30
$3.5352-week range$6.68
Loading valuation history…

Fundamentals

Key fundamentals

$253.6M

Market cap

36.8%

Revenue growth (YoY)

89.2%

Gross margin

-$86.1M

Free cash flow (USD)

-$117.6M

Net debt

Net cash position

14.7%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$0.00FY 2020$430.0KFY 2021$1.3MFY 2022$19.2MFY 2023$34.2MFY 2024$22.6MFY 2025$30.9M
$0$30.9M

Free cash flow by year

2018 → 2025

FY 2018$-24.2MFY 2019$-47.3MFY 2020$-47.5MFY 2021$-53.6MFY 2022$192.4MFY 2023$-119.3MFY 2024$-101.3MFY 2025$-86.1M
-$24.2M-$86.1M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 202589.2%
100.0%89.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventCollaboration UpdateApr 21, 2026Filing

Questions

Frequently asked questions

What is Foghorn Therapeutics Inc.'s market cap?

Foghorn Therapeutics Inc. (FHTX) has a market capitalization of $253.6M.

What is FHTX's P/E ratio?

A meaningful P/E ratio is not available for FHTX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying FHTX stock?

SEC Form 4 filings show no open-market insider buys at Foghorn Therapeutics Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CGEN

Compugen Ltd.

$254.8M

STRO

Sutro Biopharma, Inc.

$251.1M

LENZ

LENZ Therapeutics, Inc.

$249.3M

CDXS

Codexis, Inc.

$258.1M

IVA

Inventiva S.A.

$259.9M

ALEC

Alector, Inc.

$242.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.